Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantStock Option (right to buy) · Derivative | 112,000 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 11 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,000 shares Expires 2016-03-02 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantStock Option (right to buy) · Derivative | 89,674 | $0.00 Strike: $75.76 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 10 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,674 shares Expires 2011-03-01 F5 · price: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantStock Option (right to buy) · Derivative | 42,500 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 9 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,500 shares Expires 2015-02-24 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $48.24 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 8 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires 2014-02-26 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantStock Option (right to buy) · Derivative | 89,674 | $0.00 Strike: $62.09 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 7 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,674 shares Expires 2010-02-21 F5 · price: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantStock Option (right to buy) · Derivative | 105,499 | $0.00 Strike: $49.96 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 6 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 105,499 shares Expires 2013-02-27 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantStock Option (right to buy) · Derivative | 94,949 | $0.00 Strike: $58.91 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 5 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 94,949 shares Expires 2012-02-29 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantRSU - Leader Shares · Derivative | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 4 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2010-03-02 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantRestricted Stock Unit · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · derivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2010-08-01 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
OtherCommon Stock-401(k) Plan | 2,475.4088 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · nonDerivative · entry 2 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 0 F2 · price: Received as part of the Transactions in exchange for an equivalent number of shares of MSD common stock held under the MSD 401(k) plan. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:09 UTC |
FRAZIER KENNETH CExec. VP & President, GHH
|
GrantCommon Stock | 100,786.3549 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051306 · c92128_4x0.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Exec. VP & President, GHH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions"). Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:12 UTC |
GRADDICK WEIR MIRIAN MExec. V-P, Human Resources
|
GrantStock Option (right to buy) · Derivative | 62,400 | $0.00 Strike: $23.45 | $0.00 |
DisclosureSEC source: 0001209191-09-051307 · c92129_4x0.xml · derivative · entry 9 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exec. V-P, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,400 shares Expires 2019-04-23 F3 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F3 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:12 UTC |
GRADDICK WEIR MIRIAN MExec. V-P, Human Resources
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $44.30 | $0.00 |
DisclosureSEC source: 0001209191-09-051307 · c92129_4x0.xml · derivative · entry 8 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exec. V-P, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,000 shares Expires 2018-02-28 F3 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F3 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:12 UTC |
GRADDICK WEIR MIRIAN MExec. V-P, Human Resources
|
GrantStock Option (right to buy) · Derivative | 40,800 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-09-051307 · c92129_4x0.xml · derivative · entry 7 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exec. V-P, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,800 shares Expires 2017-03-01 F3 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F3 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:12 UTC |
GRADDICK WEIR MIRIAN MExec. V-P, Human Resources
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $40.70 | $0.00 |
DisclosureSEC source: 0001209191-09-051307 · c92129_4x0.xml · derivative · entry 6 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exec. V-P, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2016-08-31 F3 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F3 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:12 UTC |
GRADDICK WEIR MIRIAN MExec. V-P, Human Resources
|
GrantRSU - Leader Shares · Derivative | 6,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051307 · c92129_4x0.xml · derivative · entry 5 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exec. V-P, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,600 shares Expires 2011-02-28 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:12 UTC |
GRADDICK WEIR MIRIAN MExec. V-P, Human Resources
|
GrantRestricted Stock Unit · Derivative | 11,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051307 · c92129_4x0.xml · derivative · entry 4 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exec. V-P, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,700 shares Expires 2012-04-24 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:12 UTC |
GRADDICK WEIR MIRIAN MExec. V-P, Human Resources
|
GrantRestricted Stock Unit · Derivative | 9,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051307 · c92129_4x0.xml · derivative · entry 3 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exec. V-P, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,750 shares Expires 2011-02-28 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:12 UTC |
GRADDICK WEIR MIRIAN MExec. V-P, Human Resources
|
GrantRestricted Stock Unit · Derivative | 7,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051307 · c92129_4x0.xml · derivative · entry 2 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exec. V-P, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,650 shares Expires 2010-03-02 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:12 UTC |
GRADDICK WEIR MIRIAN MExec. V-P, Human Resources
|
GrantCommon Stock | 6,438.7503 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051307 · c92129_4x0.xml · nonDerivative · entry 1 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exec. V-P, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions"). Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:15 UTC |
KELLOGG PETER NExec. V.P. & C.F.O
|
GrantStock Option (right to buy) · Derivative | 93,600 | $0.00 Strike: $23.45 | $0.00 |
DisclosureSEC source: 0001209191-09-051308 · c92130_4x0.xml · derivative · entry 6 KELLOGG PETER N · CIK 0001226287 · Exec. V.P. & C.F.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 93,600 shares Expires 2019-04-23 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:15 UTC |
KELLOGG PETER NExec. V.P. & C.F.O
|
GrantStock Option (right to buy) · Derivative | 62,400 | $0.00 Strike: $44.30 | $0.00 |
DisclosureSEC source: 0001209191-09-051308 · c92130_4x0.xml · derivative · entry 5 KELLOGG PETER N · CIK 0001226287 · Exec. V.P. & C.F.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,400 shares Expires 2018-02-28 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:15 UTC |
KELLOGG PETER NExec. V.P. & C.F.O
|
GrantStock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $57.49 | $0.00 |
DisclosureSEC source: 0001209191-09-051308 · c92130_4x0.xml · derivative · entry 4 KELLOGG PETER N · CIK 0001226287 · Exec. V.P. & C.F.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 175,000 shares Expires 2017-11-12 F3 · price: This option vests in five equal annual installments beginning November 13, 2008, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F3 · derivative.exercise_date: This option vests in five equal annual installments beginning November 13, 2008, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:15 UTC |
KELLOGG PETER NExec. V.P. & C.F.O
|
GrantRestricted Stock Unit · Derivative | 17,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051308 · c92130_4x0.xml · derivative · entry 3 KELLOGG PETER N · CIK 0001226287 · Exec. V.P. & C.F.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,550 shares Expires 2012-04-24 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:15 UTC |
KELLOGG PETER NExec. V.P. & C.F.O
|
GrantRestricted Stock Unit · Derivative | 11,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051308 · c92130_4x0.xml · derivative · entry 2 KELLOGG PETER N · CIK 0001226287 · Exec. V.P. & C.F.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,700 shares Expires 2011-02-28 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:15 UTC |
KELLOGG PETER NExec. V.P. & C.F.O
|
GrantRestricted Stock Unit · Derivative | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051308 · c92130_4x0.xml · derivative · entry 1 KELLOGG PETER N · CIK 0001226287 · Exec. V.P. & C.F.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2013-11-13 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. 40,000 restricted stock units will vest on November 13, 2010 and 40,000 restricted stock units will vest on November 13, 2013. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. 40,000 restricted stock units will vest on November 13, 2010 and 40,000 restricted stock units will vest on November 13, 2013. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. 40,000 restricted stock units will vest on November 13, 2010 and 40,000 restricted stock units will vest on November 13, 2013. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantStock Option (right to buy) · Derivative | 224,000 | $0.00 Strike: $23.45 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 15 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 224,000 shares Expires 2019-04-23 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantStock Option (right to buy) · Derivative | 115,200 | $0.00 Strike: $44.30 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 14 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 115,200 shares Expires 2018-02-28 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantStock Option (right to buy) · Derivative | 115,200 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 13 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 115,200 shares Expires 2017-03-01 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantStock Option (right to buy) · Derivative | 96,000 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 12 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 96,000 shares Expires 2016-03-02 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantStock Option (right to buy) · Derivative | 131,874 | $0.00 Strike: $75.76 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 11 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 131,874 shares Expires 2011-03-01 F6 · price: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F6 · derivative.exercise_date: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 10 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2015-02-24 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $48.24 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 9 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2014-02-26 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantStock Option (right to buy) · Derivative | 210,998 | $0.00 Strike: $49.96 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 8 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 210,998 shares Expires 2013-02-27 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantStock Option (right to buy) · Derivative | 137,149 | $0.00 Strike: $58.91 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 7 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 137,149 shares Expires 2012-02-29 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantRSU - Leader Shares · Derivative | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 6 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2010-03-02 F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantRestricted Stock Unit · Derivative | 21,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 5 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,600 shares Expires 2011-02-28 F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantRestricted Stock Unit · Derivative | 21,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 4 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,600 shares Expires 2010-03-02 F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantPhantom Stock · Derivative | 37,388.937 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · derivative · entry 3 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,388.937 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Merck Deferral Plan, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. F3 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Merck Deferral Plan, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. F3 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Merck Deferral Plan, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
OtherCommon Stock - 401(k) Plan | 1,178.6887 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · nonDerivative · entry 2 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 0 F2 · price: Received as part of the Transactions in exchange for an equivalent number of shares of MSD common stock held under the MSD 401(k) plan. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:18 UTC |
KIM PETER SExec. V-P and Pres., MRL
|
GrantCommon Stock | 92,641.9037 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051310 · c92131_4x0.xml · nonDerivative · entry 1 KIM PETER S · CIK 0001181180 · Exec. V-P and Pres., MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions"). Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:22 UTC |
CLARK RICHARD TDirector · Chairman, President and CEO
|
GrantStock Option (right to buy) · Derivative | 732,500 | $0.00 Strike: $23.45 | $0.00 |
DisclosureSEC source: 0001209191-09-051311 · c92132_4x0.xml · derivative · entry 17 CLARK RICHARD T · CIK 0001181282 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 732,500 shares Expires 2019-04-23 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:22 UTC |
CLARK RICHARD TDirector · Chairman, President and CEO
|
GrantStock Option (right to buy) · Derivative | 615,000 | $0.00 Strike: $44.30 | $0.00 |
DisclosureSEC source: 0001209191-09-051311 · c92132_4x0.xml · derivative · entry 16 CLARK RICHARD T · CIK 0001181282 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 615,000 shares Expires 2018-02-28 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:22 UTC |
CLARK RICHARD TDirector · Chairman, President and CEO
|
GrantStock Option (right to buy) · Derivative | 320,000 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-09-051311 · c92132_4x0.xml · derivative · entry 15 CLARK RICHARD T · CIK 0001181282 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 320,000 shares Expires 2017-03-01 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:22 UTC |
CLARK RICHARD TDirector · Chairman, President and CEO
|
GrantStock Option (right to buy) · Derivative | 240,000 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001209191-09-051311 · c92132_4x0.xml · derivative · entry 14 CLARK RICHARD T · CIK 0001181282 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 240,000 shares Expires 2016-03-02 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:22 UTC |
CLARK RICHARD TDirector · Chairman, President and CEO
|
GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $34.70 | $0.00 |
DisclosureSEC source: 0001209191-09-051311 · c92132_4x0.xml · derivative · entry 13 CLARK RICHARD T · CIK 0001181282 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2015-05-04 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:22 UTC |
CLARK RICHARD TDirector · Chairman, President and CEO
|
GrantStock Option (right to buy) · Derivative | 89,674 | $0.00 Strike: $75.76 | $0.00 |
DisclosureSEC source: 0001209191-09-051311 · c92132_4x0.xml · derivative · entry 12 CLARK RICHARD T · CIK 0001181282 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,674 shares Expires 2011-03-01 F6 · price: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F6 · derivative.exercise_date: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:22 UTC |
CLARK RICHARD TDirector · Chairman, President and CEO
|
GrantStock Option (right to buy) · Derivative | 42,500 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001209191-09-051311 · c92132_4x0.xml · derivative · entry 11 CLARK RICHARD T · CIK 0001181282 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,500 shares Expires 2015-02-24 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:22 UTC |
CLARK RICHARD TDirector · Chairman, President and CEO
|
GrantStock Option (right to buy) · Derivative | 51,250 | $0.00 Strike: $48.24 | $0.00 |
DisclosureSEC source: 0001209191-09-051311 · c92132_4x0.xml · derivative · entry 10 CLARK RICHARD T · CIK 0001181282 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 51,250 shares Expires 2014-02-26 F5 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F5 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:22 UTC |
CLARK RICHARD TDirector · Chairman, President and CEO
|
GrantStock Option (right to buy) · Derivative | 89,674 | $0.00 Strike: $62.09 | $0.00 |
DisclosureSEC source: 0001209191-09-051311 · c92132_4x0.xml · derivative · entry 9 CLARK RICHARD T · CIK 0001181282 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,674 shares Expires 2010-02-21 F6 · price: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F6 · derivative.exercise_date: This option vests on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.